Business Case

Executive_Summary_Section-CSII


The implementation of insulin pump therapy is likely to result in a change in costs to both the Trust and the commissioning PCT(s). There will be some costs that are covered by the current Payment by Results tariff (which the Trust receives for standard activity); however, there may be additional costs that will require the submission of a business case. It will therefore be essential to demonstrate that the additional costs likely to be incurred are covered and remunerated appropriately.

The local arrangements for approving business cases may vary from Trust to Trust but each organisation is likely to have its own template. In some Trusts, a business case may not be required at all, and an expanded Service Level Agreement between a Trust and PCT may suffice.

Therefore the business case provided in this is guide is generic in nature and should be read in conjunction with local business case guidance. The example template that NTAC provide should be amended and adapted as appropriate. It is provided in a Word document to allow users to copy and paste appropriate material.

Insulin Pump Hardware and Consumables

There are costs attached both to the original purchase of each pump, the replacement of pumps that are coming to the end of their life and to the ongoing consumables required to support patients. NTAC project implementation sites utilised the NICE diabetes insulin pump therapy costing template (see IPT Costing Model) to assess what these costs were in their health economies, and it is recommended that Trusts moving forward also use this template to understand the financial commitments that the technology and on going consumables pose to the Trust.

Trusts wishing to implement and/or develop their insulin pump therapy service should discuss these costs with their commissioning PCT(s), alongside the most appropriate option for local demand (e.g. agreeing the total number of replacement pumps that will be required in the next five years alongside the total number of new patients who will benefit from a pump during this period).

The mechanism for funding, ordering and monitoring hardware and consumables should also be agreed with commissioning PCT(s) at this stage. NTAC project implementation sites found that purchasing the hardware and consumables and then recharging these costs to the agreed PCT(s) was an effective way to manage this process. Due attention should also be given to the procurement procedures involved in purchasing the hardware and consumables.

NTAC project implementation sites found that funding for the hardware and consumables can be agreed via two routes:

  1. Either through a service level agreement between the Trust and the commissioning PCT(s), or
  2. Through a formal business case submitted by the Trust to the PCT for this funding.

NTAC's 'How to Develop an Implemementation Team' is an important tool to understand who would needs to be involved in the discussions surrounding the purchasing of the pump technology.

Other Costs and Income

In addition to the hardware and consumable costs, there are a number of other financial considerations that need to be modelled in order to successfully implement this technology. NICE have recently revised their commissioning and benchmarking tool for insulin pump therapy, which aims to support the effective commissioning of this technology and help users to estimate the costs associated with commissioning a cost effective service. It can be used to estimate and inform the level of service needed locally and the cost of local commissioning decisions. Some tables are pre-populated with indicative costs which are based on discussions with clinicians and commissioners that NICE have consulted. You are able to modify the assumptions and variables and tailor the local cost impact to your circumstances.

If the additional service costs are in excess of the income generated by a Trust (which are not directly recharged to PCTs) then a local business case is likely to be required. The following additional costs may be required in order to scope out the cost of delivering this service, which can be added into the NICE commissioning and benchmarking tool as appropriate:

  • Staffing costs - for example, additional diabetes specialist nursing resource.
  • Training and education costs.
  • Maintenance costs.
  • Capital charges for any additional capital investment that may be required.
  • Indirect costs and overheads (e.g. operational management, HR and finance etc)

The business case should identify all relevant costs of implementing insulin pump therapy locally. If the income associated with the service is calculated to be lower than the costs of implementation then the Trust may choose to either:

  1. Approve the business case despite it not covering its costs, or
  2. Seek further local funding from PCT(s) to cover the excess cost.

Trusts must also recognise that although there may be increased expenditure in setting up and revising current insulin pump therapy services, the benefits (including a possible reduction in hospital admissions) will have an overall positive effect on the health economy. If a long term, five year financial plan is agreed, savings could also be achieved.

Future Developments

It is hoped that in the future there will be specific tariffs under the Payment by Results regime to enable Trusts to cover the costs of an insulin pump therapy service in a more accurate way than the current tariff structure enables. However work is ongoing with the NHS Information Centre for Health and Social Care to develop coding structures that will underpin the potential new tariff in the future.

Whilst the above work is being progressed, Trusts must ensure that they use an existing Office of Population Censuses and Surveys Classification (OPCS) code when fitting a pump for the first time. The insulin pump coding document explains the OPCS code in more detail and when and how it should be used in clinical practice.

  • Note: Download a local copy of the NICE insulin pump therapy costing template and NICE Commissioning and Benchmarking tool from the resources on the left-hand-side of the screen. Please enable macro's to make full use of these tools. These tools currently run from the Website when using Internet Explorer 7 - users who have earlier versions of Internet Explorer should download a local copy of the files.

Welcome to the How To Why To Guide

The NHS Technology Adoption Centre How To Why To Guides. They are designed to provide you with information about innovative medical technologies, the benefits and barriers to adoption along with practical implementation tools for your organisation.

Please agree to the terms and conditions below before entering the site.

1. Agreement

1.1 This freely accessible version of the How To Why To Guide is a generalised assessment version of a select number of Technology Implementation Projects undertaken by the NHS Technology Adoption Centre ("NTAC) that has been provided to allow you to see how adoption processes operates (the ´Guides´). The Guides are produced and made available by The NHS Technology Adoption Centre. By accessing the Guides you ("you") agree to these Terms.

1.2 These Terms form the agreement between you and us. If you do not agree to be legally bound by these Terms please leave this section of the website immediately. Your continued access and use of the website and/or the How To Why To Guide will amount to acceptance.

1.3 You are hereby granted a non-transferable, non-exclusive licence to view the Guides for your personal assessment and non-commercial purposes until your access is terminated by us.

2. Disclaimer

2.1 Liability

2.1.1 Neither NTAC, nor its contributors shall be held liable for any improper or incorrect use of the information described and/or contained on this site and NTAC assumes no responsibility for anyone´s use of the information.

2.1.2 In no event shall NTAC, or contributors be liable for any direct, indirect, incidental, special, exemplary, or consequential damages (including, but not limited to, procurement or substitute goods or services; loss of use, data, or profits; or business interruption) however caused and on any theory of liability, whether in contract, strict liability, or tort (including negligence or otherwise) arising in any way out of the use of this site or system.

2.1.3 This disclaimer of liability applies to any damages or injury, including but not limited to those caused by any failure of performance, error, omission, interruption, deletion, defect, delay in operation or transmission, computer virus, communication line failure, theft or destruction or unauthorized access to, alteration of, or use of record, whether for breach of contract, tortuous behaviour, negligence or under any other cause of action.

2.2 Warranties/Accuracy of Information

2.2.1 Although the data found using the NTAC site has been produced and processed from sources believed to be reliable, no warranty expressed or implied is made regarding accuracy, adequacy, completeness, legality, reliability or usefulness of any information.

2.2.2 This disclaimer applies to both isolated and aggregate uses of the information. NTAC provides this information on an "as is" basis. All warranties of any kind express or implied, including but not limited to the implied warranties of merchantability, fitness for a particular purpose, freedom from contamination by computer viruses and non-infringement of proprietary rights ARE DISCLAIMED.

2.2.3 Changes may be periodically added to the information contained in our "How to why to guides "; these changes may or may not be incorporated in any new version of the guide. If you have obtained information on the NTAC site from a source other than NTAC, please be aware that electronic data can be altered subsequent to original distribution. Data can also quickly become out-of-date.

2.3 Endorsement

2.3.1 NTAC is a distributor of content sometimes supplied by third parties and users. Any opinions, advice, statements, services, offers, or other information or content expressed or made available by third parties, including information providers, users, or others, are those of the respective author(s) or distributor(s) and do not necessarily state or reflect those of NTAC and shall not be used for advertising or product endorsement purposes.

2.3.2 Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not constitute or imply its endorsement, recommendation, or favouring by NTAC.

2.4 Duty to Continue Provision of "How to why to Guides"

2.4.1 Due to the dynamic nature of the Internet, resources that are publicly available one day may require restriction of access the next, and the location of items may change as menus, homepages, and files are reorganised.

2.4.2 User expressly agrees that use of NTAC site is at the user's sole risk. Neither NTAC, any entity jointly created by them, each of their affiliates nor any of their respective employees, agency, third party content providers or licenser warrant that the service will be uninterrupted or error free.

2.5 Conflicts of Interest

2.5.1 Neither NTAC, nor its contributors, have received any corporate sponsorship nor hold any financial interest in the companies manufacturing technologies described in our How to why to Guides.

3. Restrictions and intellectual property rights

3.1 The How To Why To Guide contains copyright material, trade names and marks and other proprietary information, including, but not limited to, text, software, photos and graphics ("Content"). The Content is protected by copyright law, database rights and other intellectual property rights.

3.2 The information contained here may not be converted into any other format, or transmitted in any other way, without the consent of the authors. While we encourage hyper-links to be made to this site from other parts of the Web, the pages cannot be copied and saved onto other Web servers in order to be transmitted from those servers, without permission from NTAC. This prohibition applies to those who intend to make copies of this information to retransmit as part of other Web sites; it does not apply to other Web servers which store pages for routine caching purposes.

3.3 In the event of any authorised copying, redistribution or publication of copyright material, no changes in or deletion of author attribution, trademark legend or copyright notice shall be made. You acknowledge that you do not acquire any ownership rights by downloading copyright material.

4. Limitation of liability / indemnity

You agree to defend, indemnify, and hold harmless, NTAC, its contributors, any entity jointly created by them, their respective affiliates and their respective directors, officers, employees, and agents from and against all claims and expenses, including legal fees, arising out of the use of this site or service by user or user's account.

5. External links

5.1 Every effort is made to ensure that access to the How To Why To Guide is uninterrupted and that transmissions will be error-free. However, we cannot, due to the nature of the internet, guarantee that your access will not be suspended from time to time including to allow for repairs, maintenance or the introduction of new content or facilities.

5.2 NTAC, nor its contributors are responsible for the contents of any off-site pages referenced. The user specifically acknowledges that neither NTAC or its contributors is liable for the defamatory, offensive, or illegal conduct of other users, links, or third parties and that the risk of injury from the foregoing rests entirely with the user.

5.3 The How To Why To Guide contains links including hyperlinks which may take you outside of http://www.technologyadoptioncentre.nhs.uk/how-to-why-to-guides.html. Links are provided for your convenience, and an inclusion of any link does not imply endorsement or approval by us of the linked website, its operator or content. These links are provided as an information service only. It is the responsibility to the web surfer to evaluate the content and usefulness of information obtained from other sites.

6. Governing law

6.1 These Terms are governed by English law notwithstanding the jurisdiction where you are based. You irrevocably agree that the courts of England shall have exclusive jurisdiction to settle any dispute which may arise out of, under, or in connection with these Terms and for those purposes irrevocably submit all disputes to the jurisdiction of the English courts. The place of performance shall be England.

6.2 We provide no warranty or guarantee that the Website or information available on it complies with laws other than those of England.

6.3 If any provision (or part) of this agreement is found by any court of competent jurisdiction or administrative body to be invalid, unenforceable or illegal, the other provisions shall remain in force.

7. Further information

7.1 Further information or any queries on them can be obtained from NHS Technology Adoption Centre


I agree to the terms & conditions